NEUROTOXICITY
Clinical trials for NEUROTOXICITY explained in plain language.
Never miss a new study
Get alerted when new NEUROTOXICITY trials appear
Sign up with your email to follow new studies for NEUROTOXICITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a common ED drug shield prostate cancer patients from chemo nerve pain?
Prevention CompletedThis study tested whether tadalafil, a drug often used for erectile dysfunction, can prevent nerve damage caused by docetaxel chemotherapy in men with metastatic prostate cancer. 90 participants were randomly assigned to receive either tadalafil plus standard care or standard car…
Matched conditions: NEUROTOXICITY
Phase: PHASE2 • Sponsor: Tri-Service General Hospital • Aim: Prevention
Last updated Jun 27, 2026 08:10 UTC
-
Can a common arthritis drug tame CAR-T's dangerous side effects?
Symptom relief CompletedThis phase 2 trial tested whether adding the drug anakinra (Kineret) to standard CAR-T cell therapy could prevent nerve toxicity in 15 people with relapsed or refractory non-Hodgkin lymphoma. Participants received anakinra injections for a week alongside their CAR-T infusion. The…
Matched conditions: NEUROTOXICITY
Phase: PHASE2 • Sponsor: Marcela V. Maus, M.D.,Ph.D. • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
ICU antibiotics under scrutiny: new study targets hidden brain risks
Knowledge-focused CompletedThis study followed 400 intensive care patients receiving beta-lactam antibiotics to see how often these drugs cause brain-related side effects like confusion or agitation. Researchers measured antibiotic levels in the blood and checked patients' neurological status several times…
Matched conditions: NEUROTOXICITY
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC